Clinical Trials Logo
  1. Home
  2. Neuroma
  3. NCT05008185

Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation

Neuroma Clinical Trial

Official title:
Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation: A Prospective Observational Trial"

Clinical Trial Summary

This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial

Clinical Trial Description

This will be a prospective observational study that seeks to provide a comprehensive assessment of the outcomes after RPNI surgery compared to standard of care by utilizing multiple established and validated patient-reported outcomes measures, carefully tracking pre- and post-operative pain regimens, and performing functional and physiologic tests. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05008185
Study type Observational
Source Medstar Health Research Institute
Contact Isaac C Fleming
Phone 410-554-2486
Email ike.c.fleming@medstar.net
Status Recruiting
Phase
Start date October 5, 2021
Completion date July 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT02930551 - Neuromas as the Cause of Pain N/A
Completed NCT00130962 - ALGRX 4975 in the Treatment of Patients With Morton's Neuroma Phase 2
Completed NCT02205385 - Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation N/A
Completed NCT02316262 - Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation N/A
Completed NCT04931056 - A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.
Completed NCT01632709 - Pathophysiology of Post Amputation Pain Phase 4
Completed NCT02528266 - Surgical Treatment of Symptomatic Neuroma "Stop Neuroma" N/A
Withdrawn NCT01374191 - Botulinum Toxin Type A for Neuroma Pain Phase 2
Enrolling by invitation NCT06164392 - Evaluation of Neuroma Perfusion With Indocyanine Green Fluorescence Angiography Phase 4
Completed NCT03484429 - Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain N/A
Completed NCT03051113 - Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations
Completed NCT02993276 - Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma